The Active Pharmaceutical Ingredient (API) Market is predicted to reach US$ ~353.08 billion by 2031 from US$ ~186 billion in 2020, and to grow at a CAGR of ~6% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Type [Generic and Branded], Type Of Manufacturer [Merchant (Contract) Manufacturers and Captive (In-House) Manufacturers], Application [Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Diabetes, and Respiratory Diseases]
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Sun Pharmaceutical Industries Ltd., Merck KGaA, GlaxoSmithKline plc., Cipla Inc., Pfizer Inc., Sanofi SAIS, Lilly, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2018 & 2019
2. Base Year - 2020
3. Forecasted Years - 2021 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Active Pharmaceutical Ingredient (API) Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Active Pharmaceutical Ingredient (API) Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Active Pharmaceutical Ingredient (API) Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Active Pharmaceutical Ingredient (API) Market - ANALYSIS & FORECAST, BY REGION
North America Active Pharmaceutical Ingredient (API) Market
1. North America Active Pharmaceutical Ingredient (API) Market, by Country
1. US
2. Canada
1. North America Active Pharmaceutical Ingredient (API) Market, by Product
2. North America Active Pharmaceutical Ingredient (API) Market, by Type
3. North America Active Pharmaceutical Ingredient (API) Market, by Gender
4. North America Active Pharmaceutical Ingredient (API) Market, by Sales Channel
3. Europe Active Pharmaceutical Ingredient (API) Market
1. Europe Active Pharmaceutical Ingredient (API) Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Active Pharmaceutical Ingredient (API) Market, by Product
3. Europe Active Pharmaceutical Ingredient (API) Market, by Type
4. Europe Active Pharmaceutical Ingredient (API) Market, by Gender
5. Europe Active Pharmaceutical Ingredient (API) Market, by Sales Channel
4. Asia Pacific Active Pharmaceutical Ingredient (API) Market
1. Asia Pacific Active Pharmaceutical Ingredient (API) Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Active Pharmaceutical Ingredient (API) Market, by product
3. Asia Pacific Active Pharmaceutical Ingredient (API) Market, by Type
4. Asia Pacific Active Pharmaceutical Ingredient (API) Market, by Gender
5. Asia Pacific Active Pharmaceutical Ingredient (API) Market, by Sales Channel
5. Rest of the World Active Pharmaceutical Ingredient (API) Market
1. Rest of the World Active Pharmaceutical Ingredient (API) Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Active Pharmaceutical Ingredient (API) Market, by Product
3. Rest of the World Active Pharmaceutical Ingredient (API) Market, by Type
4. Rest of the World Active Pharmaceutical Ingredient (API) Market, by Gender
5. Rest of the World Active Pharmaceutical Ingredient (API) Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 2
The Freeze-drying Pharmaceutical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Active RFID Asset Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
The Pharmaceutical Cost Management Platforms Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Pharmaceutical Purified Water Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Pharmaceutical Intellectual Property Protection Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
The Pharmaceutical Safety Assessment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...